| Original language | English |
|---|---|
| Pages (from-to) | 222-223 |
| Number of pages | 2 |
| Journal | The Lancet Neurology |
| Volume | 18 |
| Issue number | 3 |
| DOIs | |
| Publication status | Published - Mar 2019 |
Cite this
@article{c417fa674bd84b94ab8af161e209515f,
title = "Prasugrel or clopidogrel for long-term secondary stroke prevention?",
keywords = "RISK",
author = "Hankey, {Graeme J.}",
year = "2019",
month = "3",
doi = "10.1016/S1474-4422(19)30018-3",
language = "English",
volume = "18",
pages = "222--223",
journal = "The Lancet Neurology",
issn = "1474-4422",
publisher = "Academic Press",
number = "3",
}
Hankey, GJ 2019, 'Prasugrel or clopidogrel for long-term secondary stroke prevention?' The Lancet Neurology, vol. 18, no. 3, pp. 222-223. https://doi.org/10.1016/S1474-4422(19)30018-3
Prasugrel or clopidogrel for long-term secondary stroke prevention? / Hankey, Graeme J.
In: The Lancet Neurology, Vol. 18, No. 3, 03.2019, p. 222-223.Research output: Contribution to journal › Editorial
TY - JOUR
T1 - Prasugrel or clopidogrel for long-term secondary stroke prevention?
AU - Hankey, Graeme J.
PY - 2019/3
Y1 - 2019/3
KW - RISK
U2 - 10.1016/S1474-4422(19)30018-3
DO - 10.1016/S1474-4422(19)30018-3
M3 - Editorial
VL - 18
SP - 222
EP - 223
JO - The Lancet Neurology
JF - The Lancet Neurology
SN - 1474-4422
IS - 3
ER -